Moffitt program bringing patients, scientists together infuses new meaning into research

December 14, 2020

TAMPA, Fla. -- Behind every new cancer treatment and scientific breakthrough is a research team. However, because they spend most of their time in their labs, basic science researchers rarely get to meet the patients who benefit most from their work. A group at Moffitt Cancer Center decided to change that, and with the creation of the Patient Researcher Forum, the cancer center has found a way for researchers and patients to engage with each other.

A new article published in the current issue of Translational Research allows patients and their caregivers to tour labs where research is being conducted for their cancer type. They get to meet the scientists in the lab and learn about the advances and challenges in that area of research. Next, a group of researchers who have been briefed by a physician on current treatment strategies and outcomes of that specific cancer type sits down with the patient and caregiver for a roundtable discussion. This gives the patient an opportunity to talk about their cancer journey and invite researchers to ask questions.

"The Patient Researcher Forum is an example of interdisciplinary collaboration between wet and dry labs, clinicians, administrators and team members from all over our center who have come together to showcase to patients and their loved ones that they have armies of compassionate people on the research side of the institution who dedicate their lives to improving patient outcomes and quality of life," said Eric Lau, Ph.D., co-creator of the Patient Researcher Forum program and assistant member of the Tumor Biology Department and Molecular Medicine Program at Moffitt. "In exchange, we have the privilege of learning about the emotional and trying journeys that our patients have been undertaking since their diagnosis."

"The goal is to learn from one another," said Anne Bidelman, co-creator of the Patient Researcher Forum program and manager of the Patient and Family Advisory Program at Moffitt. "Basic scientists who rarely interact with patients are being given an eye-opening and often emotional experience that can inspire and reenergize their work. And patients gain a better understanding of what is being done to help them fight their cancer."

Following each Patient Researcher Forum, patients, caregivers and researchers are asked to complete a short survey about their experience. An analysis of the survey responses from 14 forums showed that this kind of experience significantly and positively impacted perspectives of researchers, patients and their caregivers. Patients noted they had a more positive outlook on the future of cancer research and gained insight on its importance. Researchers commented that the forums reinforced their decision to work in cancer research, provided a glimpse into the patient experience and helped them learn to better target their research to address patients' most relevant clinical needs.

"We found these forums not only helped break down barriers between patients and researchers, but we also discovered researchers from different programs and areas were meeting for the first time and learning from one another," said Dana Ketcher, Ph.D., applied postdoctoral fellow at Moffitt in the Health Outcomes and Behavior Department.

Moffitt is working to expand its Patient Researcher Forum program, but the organizers say they want to maintain the small, intimate nature of the meetings, as that is what has helped foster an open dialogue among participants. But they also hope other cancer centers will take this idea and create similar programs.

"The Patient Researcher Forum represents an important tool and educational model that we hope other cancer centers throughout the country will consider implementing to make sure the next generation of cancer trainees conduct research that is compassionate and patient-centered, regardless of the specific type of research they do," said Lau.
This work was supported by the National Cancer Institute (P30 CA076292, T32 CA090314) and Moffitt Cancer Center.

About Moffitt Cancer Center

Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 51 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt's scientific excellence, multidisciplinary research, and robust training and education. Moffitt is the No. 11 cancer hospital and has been nationally ranked by U.S. News & World Report since 1999. Moffitt's expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. With more than 7,000 team members, Moffitt has an economic impact in the state of $2.4 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit, and follow the momentum on Facebook, Twitter, Instagram and YouTube.

H. Lee Moffitt Cancer Center & Research Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to